Next Article in Journal
Upregulation of Leukotriene Receptors in Gastric Cancer
Next Article in Special Issue
Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
Previous Article in Journal
Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
Cancers 2011, 3(3), 3143-3155; doi:10.3390/cancers3033143
Review

Current Perspectives on Desmoid Tumors: The Mayo Clinic Approach

1
, 2
, 2,* , 3
 and 4
Received: 30 May 2011; in revised form: 6 July 2011 / Accepted: 2 August 2011 / Published: 8 August 2011
(This article belongs to the Special Issue Desmoid Tumors)
View Full-Text   |   Download PDF [1271 KB, updated 26 September 2011; original version uploaded 8 August 2011]   |   Browse Figures
Abstract: Desmoid tumors are a rare group of locally aggressive, non malignant tumors of fibroblastic origin that can lead to significant morbidity due to local invasion. Despite advances in the understanding of these tumors, their natural history is incompletely understood and the optimal treatment is still a matter of debate. Local control is the main goal of treatment and there has been a change in philosophy regarding the management of these tumors from aggressive surgical resection to function preservation. A multidisciplinary approach is essential to plan local control with acceptable morbidity. The current Mayo Clinic algorithm for the treatment of these tumors is based on institutional experience and the available evidence in the literature: asymptomatic/non progressive lesions away from vital structures are managed with observation and regular imaging; primary or recurrent desmoid tumors which are symptomatic or progressive or near vital structures are managed with wide surgical resection when wide surgical margins are possible with minimal functional and cosmetic loss. When positive or close surgical margins are likely, surgical resection with adjuvant radiotherapy or definitive radiotherapy is preferred. If likely functional or cosmetic deficit is unacceptable, radiotherapy is the treatment of choice. Unresectable lesions are considered for radiotherapy, chemotherapy or newer modalities however an unresectable lesion associated with a painful, functionless, infected extremity is managed with an amputation.
Keywords: desmoids; fibromatosis; familial adenomatous polyposis; deep fibromatosis; aggressive fibromatosis desmoids; fibromatosis; familial adenomatous polyposis; deep fibromatosis; aggressive fibromatosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Joglekar, S.B.; Rose, P.S.; Sim, F.; Okuno, S.; Petersen, I. Current Perspectives on Desmoid Tumors: The Mayo Clinic Approach. Cancers 2011, 3, 3143-3155.

AMA Style

Joglekar SB, Rose PS, Sim F, Okuno S, Petersen I. Current Perspectives on Desmoid Tumors: The Mayo Clinic Approach. Cancers. 2011; 3(3):3143-3155.

Chicago/Turabian Style

Joglekar, Siddharth B.; Rose, Peter S.; Sim, Franklin; Okuno, Scott; Petersen, Ivy. 2011. "Current Perspectives on Desmoid Tumors: The Mayo Clinic Approach." Cancers 3, no. 3: 3143-3155.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert